October 06, 2005
Human Genome Sciences' Lupus Drug Misses Test Goals
Human Genome Sciences Inc. said yesterday that its potentially lucrative new lupus drug, eagerly awaited by investors and patients, had fallen short of expectations in an important round of human testing. (Washington Post)
Posted by news editor | Filed under: Lupus
